Department of Neuroscience, University of Virginia, Charlottesville, Virginia 22908, USA.
J Neurosci. 2013 Feb 13;33(7):3079-93. doi: 10.1523/JNEUROSCI.3430-12.2013.
Ototoxicity is a main dose-limiting factor in the clinical application of aminoglycoside antibiotics. Despite longstanding research efforts, our understanding of the mechanisms underlying aminoglycoside ototoxicity remains limited. Here we report the discovery of a novel stress pathway that contributes to aminoglycoside-induced hair cell degeneration. Modifying the previously developed bioorthogonal noncanonical amino acid tagging method, we used click chemistry to study the role of protein synthesis activity in aminoglycoside-induced hair cell stress. We demonstrate that aminoglycosides inhibit protein synthesis in hair cells and activate a signaling pathway similar to ribotoxic stress response, contributing to hair cell degeneration. The ability of a particular aminoglycoside to inhibit protein synthesis and to activate the c-Jun N-terminal kinase (JNK) pathway correlated well with its ototoxic potential. Finally, we report that a Food and Drug Administration-approved drug known to inhibit ribotoxic stress response also prevents JNK activation and improves hair cell survival, opening up novel strategies to prevent and treat aminoglycoside ototoxicity.
耳毒性是氨基糖苷类抗生素临床应用的主要剂量限制因素。尽管进行了长期的研究,但我们对氨基糖苷类耳毒性的机制的理解仍然有限。在这里,我们报告了一种新的应激途径的发现,该途径导致氨基糖苷类诱导的毛细胞变性。通过改进先前开发的生物正交非规范氨基酸标记方法,我们使用点击化学来研究蛋白质合成活性在氨基糖苷类诱导的毛细胞应激中的作用。我们证明氨基糖苷类抗生素抑制毛细胞中的蛋白质合成,并激活类似于核糖体毒性应激反应的信号通路,导致毛细胞变性。特定的氨基糖苷类抗生素抑制蛋白质合成并激活 c-Jun N-末端激酶 (JNK) 途径的能力与其耳毒性潜力密切相关。最后,我们报告称,一种已被食品和药物管理局批准用于抑制核糖体毒性应激反应的药物也可防止 JNK 激活并改善毛细胞存活,为预防和治疗氨基糖苷类耳毒性开辟了新的策略。